Inflammation in the pathogenesis of microvascular complications in diabetes.
about
Anthocyanin-rich purple corn extract inhibit diabetes-associated glomerular angiogenesisChromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia.Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus.Diabetes and immunity to tuberculosis.Glyoxylate, a new marker metabolite of type 2 diabetes.Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre-diabetes - ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS).Bone marrow-derived TNF-α causes diabetic neuropathy in mice.Glucose and metformin modulate human first trimester trophoblast function: a model and potential therapy for diabetes-associated uteroplacental insufficiencyGenome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathyNuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.Predictors and prevention of diabetic cardiomyopathy.Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodyniaIL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.Establishment of an inflamed animal model of diabetic nephropathy.Cerebral ischemic damage in diabetes: an inflammatory perspective.Network Pharmacology Studies on the Bioactive Compounds and Action Mechanisms of Natural Products for the Treatment of Diabetes Mellitus: A Review.Benefits of exercise intervention in reducing neuropathic pain.Complications of Diabetes 2016Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice.The role of the immune system in the pathogenesis of diabetic complicationsA Study on the Level of Oxidative Stress and Inflammatory Markers in Type 2 Diabetes Mellitus Patients with Different Treatment Modalities.Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic rats.The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in Type 2 diabetes mellitus.Neutrophil-lymphocyte Ratio is a Novel Reliable Predictor of Nephropathy, Retinopathy, and Coronary Artery Disease in Indians with Type-2 Diabetes.Protective effect of angiotensin-(1-7) against hyperglycaemia-induced injury in H9c2 cardiomyoblast cells via the PI3K̸Akt signaling pathway.MicroRNA-146a Mimics Reduce the Peripheral Neuropathy in Type 2 Diabetic Mice.Metabolic Syndrome and Neuroprotection.Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated ComplicationsDiabetic nephropathy: newer therapeutic perspectivesTargeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy
P2860
Q21132429-803348CB-0F2A-4F60-9870-CF91DF376BD5Q30601364-79AD55FB-90E0-4FD1-900D-E7C4E98EA797Q33599279-22BED604-22F0-4002-A66D-AD82C3C77BC5Q34424824-E679BB62-43AA-4418-973F-9B90DC42BE53Q34454800-D62B2FE0-7909-4832-B910-E7B01DD86CF5Q34683974-382243B6-4476-418C-8C50-4C31F277E1D0Q34899309-919B082D-71BC-409B-99C5-4AFD31AD1E52Q35168569-22E08389-E54C-4159-B41F-ADD363F22A8FQ35739097-99EF9BE3-193F-440F-9087-E2F66E21AEA5Q35989713-3B54742F-3E3C-4081-9672-4D6E2D4069DAQ36275557-B75F03BC-538C-4D0F-9043-C308C970C970Q36776922-FE069873-7529-46F2-BE37-3D867CE20AFDQ36937533-A61DA080-7DD4-4D5D-90DE-853A251831E2Q37305013-8D542194-1374-47B8-856D-C483EE132CABQ37576010-3BA6D666-DFCE-4261-816C-E6440056033CQ37602716-8E4D2B37-3FAE-4D63-80C8-E26109734A08Q37660769-E181C2B7-D576-4B6E-BB14-56875319C115Q37697679-209BC25F-2EF8-45C0-BE94-C73AFD94F7E9Q40485268-937CA197-D528-49F4-9C6F-9E323541FEF5Q41863033-3B613089-6644-4F51-9E7F-7B1F9DE7FE64Q41872168-733A1EB4-0C5F-432E-9BCE-11AB824F7F0FQ41872494-20561793-2996-446C-9862-FA7321F849ADQ45240028-6AEC6722-298F-499A-BED3-0A9B36A4B853Q45447599-D9F52837-6FD8-4E4E-88F2-320038DB4B89Q47150777-1E8CB613-FD39-40BA-8E06-C7A8C0FBE8C3Q47246750-A63E2191-8F20-480F-A936-A4080231FFEAQ47814946-31BB885C-7B0C-49F4-8041-100F211A96F4Q53687232-DA2DB406-DC79-465E-8D6E-65313163AB42Q55237577-8FD14D41-9D7D-4362-882D-2D8AF2D421B6Q57493127-38F71217-C2E0-4B93-AED1-00825CBFAB3BQ58712499-C1C59A73-ADE2-45D5-AEDA-218F320C4EA8Q58998162-CD179B6D-81AC-4048-9317-C78AAEF3DFC4
P2860
Inflammation in the pathogenesis of microvascular complications in diabetes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inflammation in the pathogenesis of microvascular complications in diabetes.
@ast
Inflammation in the pathogenesis of microvascular complications in diabetes.
@en
Inflammation in the pathogenesis of microvascular complications in diabetes.
@nl
type
label
Inflammation in the pathogenesis of microvascular complications in diabetes.
@ast
Inflammation in the pathogenesis of microvascular complications in diabetes.
@en
Inflammation in the pathogenesis of microvascular complications in diabetes.
@nl
prefLabel
Inflammation in the pathogenesis of microvascular complications in diabetes.
@ast
Inflammation in the pathogenesis of microvascular complications in diabetes.
@en
Inflammation in the pathogenesis of microvascular complications in diabetes.
@nl
P2093
P2860
P356
P1476
Inflammation in the pathogenesis of microvascular complications in diabetes.
@en
P2093
Dung V Nguyen
Lynn C Shaw
Maria B Grant
P2860
P356
10.3389/FENDO.2012.00170
P577
2012-12-21T00:00:00Z